Israel: How are the Government, Hospitals and HMOs working together?

Faces of Digital Health

Israel: How are the Government, Hospitals and HMOs working together?

October 15, 2021

Israel: How are the Government, Hospitals and HMOs working together?

End of August Days of eHealth were organised as part of the Slovenian Presidency to the Council of EU. In four days a lot of insight was offered about healthcare digitalization in Catalonia, Germany, Portugal, Slovenia, Israel and Finland. In the previous episodes, I published the panel discussions about Germany and Catalonia. This is the panel about Israel. 


Israel has had electronic healthcare records for two decades, in 2018. A country of 9 million people, attributes 7,5% of its GDP to healthcare and is home to roughly 1,500 companies operating in the healthcare and life sciences. In the panel discussion you will learn about the national digital health strategy in Israel, how to Health Maintainance Organisations, Government, and Hospitals collaborating to advance healthcare. You will also learn a little bit more about Slovenia with two representatives of the Slovenian healthcare ecosystem.


The speakers: 

  • Esti Shelly, Director, Digital Health at Ministry of Health Israel
  • Michael Halberthal, General Director of Rambam Health Care Campus
  • Noa Kedem, Deputy Director, Digital health unit (Medical Informatics) at Maccabi Health Services  
  • Jurij Šorli, CEO of the Hospital Topolšica (Slovenia)
  • Bogdan Tušar, Acting Director General, Directorate for the Development of the Health System, Ministry of Health, Slovenia

Recap of roundtables at Days of eHealth:


The European Patient Forum’s Congress happening during 26-29 October:

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

Adopting Clinical Trial Technology: The Key to Success for Patients, Sites, & Researchers Adoption of new clinical trial technologies is critical to success. These innovations can lift patient burden, improve patient engagement, and increase equity and access to clinical trials.